Emami Ltd Q4 FY2022 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/wedf1ot1a7db0mhriyzgu4v9.pdf

Key Takeaways


Demand & Volume Environment

Mohan Goenka: "we are very optimist that Q2 there should be some bounce back for sure."

Margins: The Q1 Cliff and the Recovery Path

Mohan Goenka: "once the market stabilizes and we see a down trend you would see again we bounce back to our original 70%-72% gross margin levels... I think it is just a matter of about two quarters where we would see this kind of a decline, then we will see a benefit coming in from Q3 and Q4."

Distribution & Channel Transformation

Vinod Rao: "we share the table with a lights of Colgate and such company lot of top to top engagements, I think these are all learnings which has helped us drive growth both in e-com and modern trade."

Brand Portfolio: Hits, Misses, and Relaunches

Brand / SegmentTrendCommentary
Pain Management▲ Grew 18%Benefited from the Omicron wave in Q4; concern noted on the very high base going forward.
7 Oils in One▲ Grew 29%Seeing significant growth continuously quarter-on-quarter.
Navaratna▬ Flat (Q4), ▲ Apr-MayFlat in Q4 on a high COVID base; two-year CAGR of 13%. April and May have been good due to extreme summer; management confident it will deliver significantly well.
Kesh King▼ Declined 7%High base effect (45% growth in base quarter); two-year CAGR of 16%. Recent pricing pressure from inflation in the last two to three months. Management sees no product or off-take issue.
Boroplus▼ Declined 18%Specific reason not detailed beyond the challenging macro and subdued consumption.
Male Grooming▼ De-grewDiscretionary range hit by COVID keeping schools, colleges, and social events shut for two years. April and May showing good growth as things open up; Fair & Handsome relaunch planned.
Healthcare▲ Grew 9%Health Juice range ramped up well; D2C platform launches showing green shoots; generics and ethical business growing much better than competition.

New Bets: Dermicool, Start-ups, and the South


International Business & One-offs


Guidance & Commitments

CommitmentSpecificsTimeline
Gross margin pressure~200 bps contraction in Q1 FY23 post price hikesQ1 FY23
Gross margin recoveryBounce back to original 70%-72% levels once input costs trend downQ3 and Q4 FY23 (benefit starts)
Rural demand recovery"Some bounce back for sure"Q2 FY23
International growthDouble-digit growth despite Russia-Ukraine situationFrom Q2 FY23 onwards
Project Khoj store expansionReach 75,000 stores; add another 8,000-10,000 villages in H275,000 stores by H1 FY23; villages in H2
Dermicool distribution integrationTransition to Emami's distribution networkNext year (FY24)
Kesh King amortizationAmortization completesQ1 FY23 (June)
Advertising budgetsNo cuts planned; invest whatever is needed for growthFY23
CEO appointmentNo definite plan; will communicate if it happensUndated

Key Metrics

MetricQ4 FY22
Consolidated revenue₹770 cr, +5% YoY, two-year CAGR 20%
India business revenue growth+4% YoY, two-year CAGR 22%, flat volume growth
Gross margin62.4%, contracted 30 bps YoY
EBITDA₹164 cr, +1% YoY
Profit before tax₹104 cr, -15% YoY; includes one-off forex loss of ₹5.1 cr and lower other income
PAT₹356 cr, +4.1x YoY; includes MAT credit recognition of ₹288 cr
FY22 consolidated revenue₹3,192 cr, +11% YoY
FY22 EBITDA₹952 cr, +8% YoY
FY22 PAT₹839 cr, +85% YoY
FY22 three-year profit before tax CAGR20%
Q1 FY23 expected gross margin pressure~200 bps contraction, post price hikes
Price increase taken4.5% overall; 7%–8% on packs where increases were taken
International business revenue growth+8% YoY on a high base of +28%; excluding CIS, +17%
E-com channel growth+90% YoY; salience at 7.1% of domestic revenues
Modern trade growth+9% YoY; salience at 8.4% of domestic revenues, +60 bps
CSD revenue growth+32% YoY
Pain management range growth+9% YoY
Healthcare range growth+4% YoY
Male grooming range growth+4% YoY
7 Oils in One growth+8% YoY
Navaratna growthFlat YoY; two-year CAGR 13%, three-year CAGR 4%
Kesh King growth-7% YoY on a high base of +45%; two-year CAGR 16%
Boroplus growth-18% YoY
Project Khoj rural towns coverage40,000 towns, +8,000 in Q4; now at 42,000
Healthcare products outlets1.1 lakh outlets, +32,000 activated
Standalone modern trade outlets3,300+ outlets across 40 cities
LUP contribution to total business23%–24%
Rural-urban mixRural 54%–55%
Pledge level34%
Expected FY23 brand amortization~₹85 cr annually after Kesh King amortization ends in Q1
Expected FY23 tax rate18%–19%, with MAT credit potentially reducing it by 1–2 ppt